An Editorial Update: Should She Take Aspirin?
Authors:
- 7 June 2005
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 142 (11) , 942-943
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenNew England Journal of Medicine, 2005
- Narrative Review: Aspirin Resistance and Its Clinical ImplicationsAnnals of Internal Medicine, 2005
- Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general PracticeThe Lancet, 2001
- Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT studyJournal Of Hypertension, 2000
- Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.Journal of Clinical Investigation, 1984